Formoterol fumarate
| Title | Journal |
|---|---|
| Formoterol synergy with des-ciclesonide inhibits IL-4 expression in IgE/antigen-induced mast cells by inhibiting JNK activation. | European journal of pharmacology 20150815 |
| Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studies. | International journal of chronic obstructive pulmonary disease 20140101 |
| Potentiated interaction between ineffective doses of budesonide and formoterol to control the inhaled cadmium-induced up-regulation of metalloproteinases and acute pulmonary inflammation in rats. | PloS one 20140101 |
| Tiotropium increases PPARγ and decreases CREB in cells isolated from induced sputum of COPD patients. | Advances in experimental medicine and biology 20130101 |
| Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice. | Respiratory medicine 20121201 |
| Development and validation of a ultra high performance liquid chromatography-tandem mass spectrometric method for the direct detection of formoterol in human urine. | Journal of pharmaceutical and biomedical analysis 20121101 |
| Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids. | Respiratory medicine 20121101 |
| Cosuspensions of microcrystals and engineered microparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers. | Langmuir : the ACS journal of surfaces and colloids 20121023 |
| Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition. | British journal of pharmacology 20121001 |
| Bronchoprotection in conscious guinea pigs by budesonide and the NO-donating analogue, TPI 1020, alone and combined with tiotropium or formoterol. | British journal of pharmacology 20121001 |
| Bronchodilators modulate inflammation in chronic obstructive pulmonary disease subjects. | Pharmacological research 20121001 |
| Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD. | Respiratory medicine 20121001 |
| COPD treatment: real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. | Pulmonary pharmacology & therapeutics 20121001 |
| Relief of methacholine-induced bronchospasm with extrafine beclomethasone dipropionate/formoterol in comparison with salbutamol in asthma. | Pulmonary pharmacology & therapeutics 20121001 |
| NMR characterisation of structure in solvates and polymorphs of formoterol fumarate. | Magnetic resonance in chemistry : MRC 20121001 |
| Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease. | The Cochrane database of systematic reviews 20120912 |
| The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation. | Basic research in cardiology 20120901 |
| Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers. | The Journal of pharmacy and pharmacology 20120901 |
| Corticosteroids and β₂-agonists upregulate mitogen-activated protein kinase phosphatase 1: in vitro mechanisms. | British journal of pharmacology 20120801 |
| ADRB2 polymorphisms and budesonide/formoterol responses in COPD. | Chest 20120801 |
| Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: a randomized controlled trial. | The Journal of allergy and clinical immunology 20120801 |
| Long-acting β2 agonists and corticosteroids restore the reduction of histone deacetylase activity and inhibit H2O2-induced mediator release from alveolar macrophages. | Pulmonary pharmacology & therapeutics 20120801 |
| Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models. | The Journal of pharmacology and experimental therapeutics 20120801 |
| Selective β2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia-reperfusion injury. | Arteriosclerosis, thrombosis, and vascular biology 20120801 |
| Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action. | Pulmonary pharmacology & therapeutics 20120801 |
| Pseudobronchiectasis after pertussis and mycoplasma infection. | American journal of respiratory and critical care medicine 20120801 |
| The clinical impact of single inhaler therapy in asthma. | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20120701 |
| The β2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis. | The Journal of pharmacology and experimental therapeutics 20120701 |
| Lung epithelial-C/EBPβ contributes to LPS-induced inflammation and its suppression by formoterol. | Biochemical and biophysical research communications 20120622 |
| Mometasone/formoterol inhalation aerosol: in asthma uncontrolled on medium- or high-dose inhaled corticosteroids. | Drugs 20120618 |
| Acute and short-term effect of an extra dose of formoterol in COPD patients. | Respiratory medicine 20120601 |
| Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status. | Respiratory medicine 20120601 |
| Increased corticosteroid sensitivity by a long acting β2 agonist formoterol via β2 adrenoceptor independent protein phosphatase 2A activation. | Pulmonary pharmacology & therapeutics 20120601 |
| Effect of switching from salmeterol/fluticasone to formoterol/ budesonide combinations in patients with uncontrolled asthma. | Allergology international : official journal of the Japanese Society of Allergology 20120601 |
| Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysis. | Drug testing and analysis 20120601 |
| A randomised, placebo- and active-controlled dose-finding study of aclidinium bromide administered twice a day in COPD patients. | Pulmonary pharmacology & therapeutics 20120601 |
| [Clinical effects of budesonide/formoterol combination drug in elder patients with asthma compared with budesonide plus tulobuterol patch combination treatment]. | Arerugi = [Allergy] 20120601 |
| The β2-adrenoceptor agonist formoterol improves structural and functional regenerative capacity of skeletal muscles from aged rat at the early stages of postinjury. | The journals of gerontology. Series A, Biological sciences and medical sciences 20120501 |
| Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma. | Respirology (Carlton, Vic.) 20120501 |
| Targeting airway remodelling in asthma: the how, what and where? | Respirology (Carlton, Vic.) 20120501 |
| Inhalation of corticosteroid and β-agonist for persistent cough following pulmonary resection. | General thoracic and cardiovascular surgery 20120501 |
| Rhinovirus-induced MMP-9 expression is dependent on Fra-1, which is modulated by formoterol and dexamethasone. | Journal of immunology (Baltimore, Md. : 1950) 20120501 |
| Capillary electrochromatography of three β2-agonists in human urine using a lauryl methacrylate-based monolithic column. | Journal of separation science 20120501 |
| Regular treatment with formoterol for chronic asthma: serious adverse events. | The Cochrane database of systematic reviews 20120418 |
| Ciclesonide inhibits TNFα- and IL-1β-induced monocyte chemotactic protein-1 (MCP-1/CCL2) secretion from human airway smooth muscle cells. | American journal of physiology. Lung cellular and molecular physiology 20120415 |
| Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro. | International journal of pharmaceutics 20120415 |
| Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis. | Journal of clinical pharmacy and therapeutics 20120401 |
| AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD. | Respiratory medicine 20120401 |
| Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study. | Therapeutic advances in respiratory disease 20120401 |
| The effect of formoterol on peritoneal VEGF levels in rats with endometriosis. | Cytokine 20120401 |
| Additive anti-inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells. | Pulmonary pharmacology & therapeutics 20120401 |
| Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma. | Clinical drug investigation 20120401 |
| In vitro evaluation of powders for inhalation: the effect of drug concentration on particle detachment. | International journal of pharmaceutics 20120315 |
| Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events. | The Cochrane database of systematic reviews 20120314 |
| Onset of action of formoterol versus salmeterol via dry powder inhalers in moderate chronic obstructive pulmonary disease: a randomized, placebo-controlled, double-blind, crossover study. | Clinical drug investigation 20120301 |
| The effect of budesonide/formoterol pressurized metered-dose inhaler on predefined criteria for worsening asthma in four different patient populations with asthma. | Drugs in R&D 20120301 |
| Clinical efficacy and safety of budesonide-formoterol in non-cystic fibrosis bronchiectasis. | Chest 20120201 |
| Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function. | The European respiratory journal 20120201 |
| Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study. | Respiratory medicine 20120201 |
| Real-life prospective study on asthma control in Italy: cross-sectional phase results. | Respiratory medicine 20120201 |
| Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease. | Current medical research and opinion 20120201 |
| β2-Agonists upregulate PDE4 mRNA but not protein or activity in human airway smooth muscle cells from asthmatic and nonasthmatic volunteers. | American journal of physiology. Lung cellular and molecular physiology 20120201 |
| Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study. | Respiratory medicine 20120201 |
| Budesonide/formoterol pressurized metered-dose inhaler versus budesonide: a randomized controlled trial in black patients with asthma. | The Journal of asthma : official journal of the Association for the Care of Asthma 20120201 |
| Airways hyperresponsiveness to different inhaled combination therapies in adolescent asthmatics. | European annals of allergy and clinical immunology 20120201 |
| Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study. | Respiratory medicine 20120101 |
| Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study. | Clinical drug investigation 20120101 |
| A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats. | Xenobiotica; the fate of foreign compounds in biological systems 20120101 |
| Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial. | International journal of chronic obstructive pulmonary disease 20120101 |
| Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD. | International journal of chronic obstructive pulmonary disease 20120101 |
| Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials. | International journal of chronic obstructive pulmonary disease 20120101 |
| Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial. | BMC pediatrics 20120101 |
| Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease. | The Cochrane database of systematic reviews 20120101 |
| Do inhaled corticosteroid/long-acting beta2-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisal. | Allergy and asthma proceedings 20120101 |
| [The influence of treatment with formoterol, formoterol with tiotropium, formoterol with inhaled glucocorticosteroid and tiotropium on lung functions, tolerance of exercise and simple, morning everyday activities in patients with chronic obstructive pulmonary disease (COPD)]. | Pneumonologia i alergologia polska 20120101 |
| [A pharmacovigilance study in chest diseases outpatient clinic]. | Tuberkuloz ve toraks 20120101 |
| Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis. | International journal of chronic obstructive pulmonary disease 20120101 |
| Evaluation of the efficacy and safety of a fixed-dose, single-capsule budesonide-formoterol combination in uncontrolled asthma: a randomized, double-blind, multicenter, controlled clinical trial. | Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20120101 |
| Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. | The Cochrane database of systematic reviews 20120101 |
| Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews. | The Cochrane database of systematic reviews 20120101 |
| Influenza infects lung microvascular endothelium leading to microvascular leak: role of apoptosis and claudin-5. | PloS one 20120101 |
| Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. | The Cochrane database of systematic reviews 20111207 |
| Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. | The Cochrane database of systematic reviews 20111207 |
| Effect of AeroChamber Plus™ on the lung and systemic bioavailability of beclometasone dipropionate/formoterol pMDI. | British journal of clinical pharmacology 20111201 |
| Aerosol tribocharging and its relation to the deposition of Oxis™ Turbuhaler® in the electrical next generation impactor. | Journal of pharmaceutical sciences 20111201 |
| Agonist- and hydrogen peroxide-mediated oxidation of the β2 adrenergic receptor: evidence of receptor s-sulfenation as detected by a modified biotin-switch assay. | The Journal of pharmacology and experimental therapeutics 20111201 |
| Modulation of β-adrenergic receptors in the ventromedial hypothalamus influences counterregulatory responses to hypoglycemia. | Diabetes 20111201 |
| Mometasone furoate/formoterol in the treatment of persistent asthma. | Expert review of respiratory medicine 20111201 |
| Long-acting β-agonists in asthma management: what is the current status? | Drugs 20111112 |
| Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD. | Contemporary clinical trials 20111101 |
| An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations. | Southern medical journal 20111101 |
| Inhaled therapy for acute COPD exacerbation in the hospital: are we missing the low-hanging fruit? | Southern medical journal 20111101 |
| Single maintenance and reliever therapy (SMART) for asthma. | Drug and therapeutics bulletin 20111101 |
| Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. | The Cochrane database of systematic reviews 20111005 |
| Comparison of budesonide/formoterol Turbuhaler with fluticasone/salmeterol Diskus for treatment effects on small airway impairment and airway inflammation in patients with asthma. | Pulmonary pharmacology & therapeutics 20111001 |
| Formoterol by pressurized metered-dose aerosol or dry powder on airway obstruction and lung hyperinflation in partially reversible COPD. | Journal of aerosol medicine and pulmonary drug delivery 20111001 |
| [What helps for persistent symptoms of asthma during inhalative steroid therapy?]. | Deutsche medizinische Wochenschrift (1946) 20111001 |
| Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: an AFM and Raman investigation. | Journal of colloid and interface science 20110915 |
| Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. | Lancet (London, England) 20110910 |
| Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide/formoterol. | American journal of respiratory cell and molecular biology 20110901 |
| Effect of different asthma treatments on risk of cold-related exacerbations. | The European respiratory journal 20110901 |
| TGFβ-induced matrix production by bronchial fibroblasts in asthma: budesonide and formoterol effects. | Respiratory medicine 20110901 |
| Safe use of long-acting β-agonists: what have we learnt? | Expert opinion on drug safety 20110901 |
| Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20110901 |
| The effects of inhaled formoterol on the autonomic nervous system in adolescents with asthma. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20110901 |
| Validation of the AQLQ12+ among adolescents and adults with persistent asthma. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20110801 |
| Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD. | Respiratory medicine 20110801 |
| A cumulative dose, safety and tolerability study of arformoterol in pediatric subjects with stable asthma. | Pediatric pulmonology 20110801 |
| Controversies regarding long-acting β2-agonists. | Current opinion in allergy and clinical immunology 20110801 |
| Towards the Grade of Recommendations, Assessment, Development and Evaluation system: methods and results of budesonide/formoterol maintenance and reliever therapy research. | Current opinion in allergy and clinical immunology 20110801 |
| Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination. | The Journal of asthma : official journal of the Association for the Care of Asthma 20110801 |
| Postexposure administration of a {beta}2-agonist decreases chlorine-induced airway hyperreactivity in mice. | American journal of respiratory cell and molecular biology 20110701 |
| Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD. | Respiratory medicine 20110701 |
| Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials. | International journal of clinical practice 20110701 |
| Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting. | The clinical respiratory journal 20110701 |
| Safety of formoterol in adults and children with asthma: a meta-analysis. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20110701 |
| The effect of formoterol on airway goblet cell hyperplasia and protein Muc5ac expression in asthmatic mice. | European review for medical and pharmacological sciences 20110701 |
| Audit of budesonide/formoterol prescribing for asthma in community pharmacy in the U.K. | Respiratory medicine 20110601 |
| Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms. | British journal of pharmacology 20110601 |
| Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol. | The Journal of pharmacology and experimental therapeutics 20110601 |
| Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD. | Respiratory medicine 20110601 |
| Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD. | Respiratory medicine 20110601 |
| Comparing asthma treatment in elderly versus younger patients. | Respiratory medicine 20110601 |
| Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: workshop summary report. | Journal of aerosol medicine and pulmonary drug delivery 20110601 |
| Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy. | Journal of clinical pharmacy and therapeutics 20110601 |
| Triple inhalers for obstructive airways disease: will they be useful? | Expert review of respiratory medicine 20110601 |
| Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler. | Respiratory medicine 20110501 |
| The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis. | Pharmacology & therapeutics 20110501 |
| Cost effectiveness of budesonide/formoterol added to tiotropium bromide versus placebo added to tiotropium bromide in patients with chronic obstructive pulmonary disease: Australian, Canadian and Swedish healthcare perspectives. | PharmacoEconomics 20110501 |
| [Clinical study concerning anti-inflammatory effect of fixed dose therapy by budesonide/formoterol combination inhaler for moderate persistent asthmatics]. | Arerugi = [Allergy] 20110501 |
| Methacholine challenge as a clinical bioassay of pulmonary delivery of a long-acting β₂-adrenergic agonist. | Pharmacotherapy 20110501 |
| Beta agonist use during asthma exacerbations: how much is too much? | The New Zealand medical journal 20110415 |
| The reassertion profiles of long acting β2-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant β2-adrenoceptor. | Pulmonary pharmacology & therapeutics 20110401 |
| Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD. | Respiratory medicine 20110401 |
| [In vitro study on the mechanism of myocardial injury induced by Formoterol and the protective effect of Budesonide in rats]. | Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 20110301 |
| Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender. | Pulmonary pharmacology & therapeutics 20110201 |
| Rapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPD. | Pulmonary pharmacology & therapeutics 20110201 |
| Effect of mometasone furoate (MF)/formoterol fumarate (F) combination (MF/F) on late-phase responses in allergen-challenged Brown Norway rats. | Pulmonary pharmacology & therapeutics 20110201 |
| An assessment of change in asthma control among adolescents and adults with persistent asthma in mometasone furoate/formoterol fumarate clinical trials. | The Journal of asthma : official journal of the Association for the Care of Asthma 20110201 |
| Comparison of tiotropium plus formoterol to tiotropium alone in stable chronic obstructive pulmonary disease: a meta-analysis. | Respirology (Carlton, Vic.) 20110201 |
| The role of β-adrenergic receptors in the cardioprotective effects of beta-preconditioning (βPC). | Cardiovascular drugs and therapy 20110201 |
| Effects of formoterol on protein metabolism in myotubes during hyperthermia. | Muscle & nerve 20110201 |
| [Asthma: new insights and advances in treatment]. | Deutsche medizinische Wochenschrift (1946) 20110201 |
| Chronic formoterol administration reduces cardiac mitochondrial protein synthesis and oxidative capacity in mice. | International journal of cardiology 20110121 |
| A short-term investigation of dysphonia in asthmatic patients using inhaled budesonide. | Journal of voice : official journal of the Voice Foundation 20110101 |
| Sodium cromoglycate and eformoterol attenuate sensitivity and reactivity to inhaled mannitol in subjects with bronchiectasis. | Respirology (Carlton, Vic.) 20110101 |
| Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma. | Acta pharmacologica Sinica 20110101 |
| Don't 'agonise' over the mechanisms underlying beta-agonist-induced muscle hypertrophy! | The Journal of physiology 20110101 |
| Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. | Respiratory research 20110101 |
| [Indacaterol--a new hope for maximising bronchodilation?]. | Pneumologia (Bucharest, Romania) 20110101 |
| Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study. | BMC pulmonary medicine 20110101 |
| No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study. | BMC clinical pharmacology 20110101 |
| Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis. | International journal of chronic obstructive pulmonary disease 20110101 |
| Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. | BMC pulmonary medicine 20110101 |
| Antiasthmatic effects of hesperidin, a potential Th2 cytokine antagonist, in a mouse model of allergic asthma. | Mediators of inflammation 20110101 |
| Dose-response curve to salbutamol during acute and chronic treatment with formoterol in COPD. | International journal of chronic obstructive pulmonary disease 20110101 |
| Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management. | Journal of medical economics 20110101 |
| Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients. | International journal of chronic obstructive pulmonary disease 20110101 |
| Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: phase III study results. | BMC pulmonary medicine 20110101 |
| Budesonide and formoterol reduce early innate anti-viral immune responses in vitro. | PloS one 20110101 |
| Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial. | BMC pulmonary medicine 20110101 |
| Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study. | Allergy and asthma proceedings 20110101 |
| Interactive inhibitory effects of formoterol and montelukast on activated human neutrophils. | The European respiratory journal 20101201 |
| Clenbuterol and formoterol decrease force production in isolated intact mouse skeletal muscle fiber bundles through a beta2-adrenoceptor-independent mechanism. | Journal of applied physiology (Bethesda, Md. : 1985) 20101201 |
| Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma. | The Journal of asthma : official journal of the Association for the Care of Asthma 20101201 |
| Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic {beta}-adrenoceptor stimulation in mice. | The Journal of physiology 20101201 |
| Beclomethasone/formoterol in the management of COPD: a randomised controlled trial. | Respiratory medicine 20101201 |
| Safety of formoterol in children and adolescents: experience from asthma clinical trials. | Archives of disease in childhood 20101201 |
| Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPD. | Expert review of respiratory medicine 20101201 |
| Effects of formoterol and ipratropium bromide on repeated cadmium inhalation-induced pulmonary inflammation and emphysema in rats. | European journal of pharmacology 20101125 |
| Mometasone/Formoterol (dulera) for asthma. | The Medical letter on drugs and therapeutics 20101018 |
| [Cost effectiveness of BDP/formoterol fixed vs. two single inhalers in the treatment of bronchial asthma]. | MMW Fortschritte der Medizin 20101014 |
| Energy expenditure and impact of bronchodilators in COPD patients. | Respiratory medicine 20101001 |
| Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. | Respiratory medicine 20101001 |
| Budesonide/formoterol in the treatment of asthma. | Expert review of respiratory medicine 20101001 |
| Call for withdrawal of LABA single-therapy inhaler in asthma. | Lancet (London, England) 20100904 |
| Management of severe asthma in children. | Lancet (London, England) 20100904 |
| Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment. | Allergy 20100901 |
| Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD. | Respiratory medicine 20100901 |
| Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy. | The European respiratory journal 20100901 |
| Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma. | Pediatrics 20100901 |
| Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study. | African journal of medicine and medical sciences 20100901 |
| Human airway contraction and formoterol-induced relaxation is determined by Ca2+ oscillations and Ca2+ sensitivity. | American journal of respiratory cell and molecular biology 20100801 |
| Measuring asthma control: a comparison of three classification systems. | The European respiratory journal 20100801 |
| Effect of formoterol and budesonide on chemokine release, chemokine receptor expression and chemotaxis in human neutrophils. | Pulmonary pharmacology & therapeutics 20100801 |
| Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal. | Thorax 20100801 |
| Short-term increase of serum troponin I and serum heart-type fatty acid-binding protein (H-FABP) in dogs following administration of formoterol. | Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20100701 |
| Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages. | The European respiratory journal 20100701 |
| Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. | Allergy 20100701 |
| Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence. | Clinical therapeutics 20100701 |
| Advantages of endurance treadmill walking compared with cycling to assess bronchodilator therapy. | Chest 20100601 |
| Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design. | Pulmonary pharmacology & therapeutics 20100601 |
| Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. | Journal of aerosol medicine and pulmonary drug delivery 20100601 |
| Randomized trial to evaluate efficacy and safety of combination budesonide and formoterol and new FDA mandate regarding LABAs. | Hospital practice (1995) 20100601 |
| Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD. | Thorax 20100601 |
| [Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma]. | Pneumologie (Stuttgart, Germany) 20100601 |
| Exercise-induced wheeze: Fraction of exhaled nitric oxide-directed management. | Respirology (Carlton, Vic.) 20100501 |
| Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action. | British journal of pharmacology 20100501 |
| Can low-dose combination products for inhalation be formulated in single crystalline particles? | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100416 |
| The role of budesonide/formoterol for maintenance and relief in the management of asthma. | Pulmonary pharmacology & therapeutics 20100401 |
| Arformoterol tartrate in the treatment of COPD. | Expert review of respiratory medicine 20100401 |
| Stopping long-acting beta-2 agonists. | The Medical letter on drugs and therapeutics 20100322 |
| Effects of formoterol on contraction and Ca2+ signaling of mouse airway smooth muscle cells. | American journal of respiratory cell and molecular biology 20100301 |
| Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells. | Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 20100301 |
| Overall asthma control: the relationship between current control and future risk. | The Journal of allergy and clinical immunology 20100301 |
| Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma. | The Journal of asthma : official journal of the Association for the Care of Asthma 20100301 |
| SMART isn't. | The Journal of allergy and clinical immunology 20100301 |
| Formoterol for acute asthma in the emergency department: a systematic review with meta-analysis. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20100301 |
| Anti-inflammatory effects of formoterol and ipratropium bromide against acute cadmium-induced pulmonary inflammation in rats. | European journal of pharmacology 20100225 |
| The asymmetric synthesis of (R,R)-formoterol via transfer hydrogenation with polyethylene glycol bound Rh catalyst in PEG2000 and water. | Chirality 20100201 |
| Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. | The Journal of allergy and clinical immunology 20100201 |
| Budesonide/formoterol dry powder in asthma: an option for control as maintenance and reliever therapy. | Expert opinion on pharmacotherapy 20100201 |
| Safety of formoterol in patients with asthma: combined analysis of data from double-blind, randomized controlled trials. | The Journal of allergy and clinical immunology 20100201 |
| The safety and efficacy of arformoterol and formoterol in COPD. | COPD 20100201 |
| Is the maintenance and reliever approach the answer? | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20100201 |
| A simple analysis of a simple crossover trial with a dichotomous outcome measure. | Statistics in medicine 20100130 |
| Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. | The Cochrane database of systematic reviews 20100120 |
| [Efficacy and safety of a beta2-agonist-combination in patients with bronchial asthma--a clinical practice surveillance study]. | MMW Fortschritte der Medizin 20100114 |
| Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. | Nature 20100107 |
| Exercise capacity and cytochrome oxidase activity in muscle mitochondria of COPD patients. | Respiratory medicine 20100101 |
| Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology. | The American journal of pathology 20100101 |
| The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children. | Allergy and asthma proceedings 20100101 |
| The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter. | Allergy and asthma proceedings 20100101 |
| Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma. | Allergy and asthma proceedings 20100101 |
| Comparative bioavailability of two hydrofluoroalkane formulations of formoterol fumarate both delivered by pressurised metered dose inhaler. | Arzneimittel-Forschung 20100101 |
| [Agonists of beta2 adrenergic receptor in the therapy of obstructive diseases]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20100101 |
| Managing outpatient asthma exacerbations. | Current allergy and asthma reports 20100101 |
| Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. | The Cochrane database of systematic reviews 20100101 |
| beta2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cells. | BMC pulmonary medicine 20100101 |
| Budesonide/formoterol pressurized metered-dose inhaler for patients with persistent asthma. | Allergy and asthma proceedings 20100101 |
| Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. | Respiratory research 20100101 |
| Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study. | Clinical drug investigation 20100101 |
| Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study. | Clinical drug investigation 20100101 |
| Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids. | Allergy and asthma proceedings 20100101 |
| Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids. | Allergy and asthma proceedings 20100101 |
| Nebulized formoterol: a review of clinical efficacy and safety in COPD. | International journal of chronic obstructive pulmonary disease 20100101 |
| Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. | The Cochrane database of systematic reviews 20100101 |
| [Budesonide/formoterol in the treatment of COPD]. | Archivos de bronconeumologia 20100101 |
| A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma. | Journal of postgraduate medicine 20100101 |
| Budesonide/formoterol combination in COPD: a US perspective. | International journal of chronic obstructive pulmonary disease 20100101 |
| Dyspnea in COPD: beyond the modified Medical Research Council scale. | Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20100101 |
| Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. | Sao Paulo medical journal = Revista paulista de medicina 20100101 |
| [Importance and variability of symptoms in chronic obstructive pulmonary disease. Their significance for treatment]. | Archivos de bronconeumologia 20100101 |
| [Triple therapy in chronic obstructive pulmonary disease]. | Archivos de bronconeumologia 20100101 |
| Bronchodilator effects of indacaterol and formoterol in patients with COPD. | Pulmonary pharmacology & therapeutics 20091201 |
| On the superiority of BDP/FF HFA pMDI fixed combination over the free combination of BDP CFC pMDI and FF DPI. | Respiratory medicine 20091201 |
| Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials. | Respiratory medicine 20091201 |
| Pharmacogenetics of beta(2)-agonists in children. | The Journal of allergy and clinical immunology 20091201 |
| [Do fixed combinations increase effectiveness in asthma bronchiale?]. | Deutsche medizinische Wochenschrift (1946) 20091201 |
| [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?]. | Deutsche medizinische Wochenschrift (1946) 20091201 |
| Can patients with asthma feel inhaler therapy working right away? Two clinical trials testing the effect of timing of assessment on patient perception. | The Journal of asthma : official journal of the Association for the Care of Asthma 20091201 |
| Inhaled BDP/formoterol extra-fine combination. Evidence and future perspectives. | Pneumologie (Stuttgart, Germany) 20091201 |
| Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. | Clinical therapeutics 20091201 |
| Budesonide/formoterol effects on metalloproteolytic balance in TGFbeta-activated human lung fibroblasts. | Respiratory medicine 20091101 |
| Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus. | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20091101 |
| Metalloproteolytic balance in asthma: when and how could its regulation? | Respiratory medicine 20091101 |
| Budesonide/formoterol maintenance and reliever therapy versus conventional best practice. | Respiratory medicine 20091101 |
| The influence of breathing pattern during nebulization on the delivery of arformoterol using a breath simulator. | Respiratory care 20091101 |
| Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. | Advances in therapy 20091101 |
| Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. | American journal of respiratory and critical care medicine 20091015 |
| Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events. | The Cochrane database of systematic reviews 20091007 |
| 24-hour bronchodilator efficacy of single doses of indacaterol in patients with persistent asthma: comparison with placebo and formoterol. | Current medical research and opinion 20091001 |
| A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management. | International journal of clinical practice 20091001 |
| Output and aerosol properties of 5 nebulizer/compressor systems with arformoterol inhalation solution. | Respiratory care 20091001 |
| Risk of mortality associated with formoterol: a systematic review and meta-analysis. | The European respiratory journal 20091001 |
| Combination of formoterol and tiotropium in the treatment of COPD: effects on lung function. | COPD 20091001 |
| [Treatments targeting distal airways in asthma: update on clinical studies]. | Revue des maladies respiratoires 20091001 |
| Budesonide/formoterol combination as a maintenance and rescue therapy: physicians' perspectives. | The Journal of asthma : official journal of the Association for the Care of Asthma 20090901 |
| [Efficacy and safety of budesonide/formoterol dry powder inhalation for treatment of childhood asthma]. | Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20090901 |
| A randomized, comparative study of formoterol and terbutaline dry powder inhalers in the treatment of mild to moderate asthma exacerbations in the pediatric acute care setting. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20090901 |
| Use of formoterol in the treatment of stuttering. A pilot study. | Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20090901 |
| [Prospective evaluation of the efficacy of the combination of budesonide/formoterol in obstructive airway disease after allogeneic hematopoietic stem cell transplantation]. | Revue des maladies respiratoires 20090901 |
| Budesonide and the risk of pneumonia: a meta-analysis of individual patient data. | Lancet (London, England) 20090829 |
| Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. | Therapeutic advances in respiratory disease 20090801 |
| Salmeterol and formoterol: asthma aggravation. Use should be restricted. | Prescrire international 20090801 |
| [Long-acting beta2-agonist bronchodilators safety for asthma treatment]. | Archivos argentinos de pediatria 20090801 |
| Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study. | Clinical therapeutics 20090801 |
| Budesonide/formoterol pressurized metered-dose inhaler: in chronic obstructive pulmonary disease. | Drugs 20090730 |
| Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20090701 |
| Allergies in India: a study on medication compliance. | Journal of the Indian Medical Association 20090701 |
| Relationship between exhaled nitric oxide and IgE sensitisation in patients with asthma: influence of steroid treatment. | The clinical respiratory journal 20090701 |
| Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark--cost-effectiveness analysis based on five randomised controlled trials. | The clinical respiratory journal 20090701 |
| Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. | Drugs 20090618 |
| Effectiveness of combination therapies in asthma: an observational study. | Pulmonary pharmacology & therapeutics 20090601 |
| Bronchoconstriction induced by hyperventilation with humidified hot air: role of TRPV1-expressing airway afferents. | Journal of applied physiology (Bethesda, Md. : 1985) 20090601 |
| In vitro drug delivery performance of a new budesonide/formoterol pressurized metered-dose inhaler. | Journal of aerosol medicine and pulmonary drug delivery 20090601 |
| Efficacy and safety of budesonide/formeterol combination therapy in asthma patients. | Collegium antropologicum 20090601 |
| Characterization and in vitro evaluation of the formoterol/cyclodextrin complex for pulmonary administration by nebulization. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20090501 |
| Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. | The Journal of allergy and clinical immunology 20090501 |
| [Long-acting bronchodilators (formoterol and salmeterol) for treatment of asthma. Comment of the German Airway League and the German Respiratory Society]. | Pneumologie (Stuttgart, Germany) 20090501 |
| Esophageal candidiasis--an adverse effect of inhaled corticosteroids therapy. | The Journal of asthma : official journal of the Association for the Care of Asthma 20090501 |
| Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. | The Cochrane database of systematic reviews 20090415 |
| [Long acting beta-2 agonists. Discussion of their use in asthma]. | MMW Fortschritte der Medizin 20090409 |
| Chiral HPLC analysis of formoterol stereoisomers and thermodynamic study of their interconversion in aqueous pharmaceutical formulations. | Journal of pharmaceutical and biomedical analysis 20090405 |
| Effect of formoterol with or without budesonide in repeated low-dose allergen challenge. | The European respiratory journal 20090401 |
| In vitro deposition properties of nebulized formoterol fumarate: effect of nebulization time, airflow, volume of fill and nebulizer type. | Current medical research and opinion 20090401 |
| Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. | Respiratory medicine 20090401 |
| [Long-acting bronchodilators (formoterol and salmeterol) for treatment of asthma]. | Pneumologie (Stuttgart, Germany) 20090401 |
| Use of dry powder inhalers in acute exacerbations of asthma and COPD. | Therapeutic advances in respiratory disease 20090401 |
| Asthma and COPD according to the pulmonologist. | Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20090401 |
| The economic impact of severe asthma to low-income families. | Allergy 20090301 |
| Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium/albuterol MDI. | Current medical research and opinion 20090301 |
| Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial. | Drugs 20090301 |
| An analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma. | Irish medical journal 20090301 |
| Spray drying of budesonide, formoterol fumarate and their composites--I. Physicochemical characterisation. | International journal of pharmaceutics 20090209 |
| Spray drying of budesonide, formoterol fumarate and their composites-II. Statistical factorial design and in vitro deposition properties. | International journal of pharmaceutics 20090209 |
| Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol. | Respiratory medicine 20090201 |
| Importance of adrenergic receptors in prenatally induced cognitive impairment in the domestic chick. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20090201 |
| Sensitivity of disease parameters to flexible budesonide/formoterol treatment in an allergic rat model. | Pulmonary pharmacology & therapeutics 20090201 |
| Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study. | Pulmonary pharmacology & therapeutics 20090201 |
| 24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterol. | Current medical research and opinion 20090201 |
| Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study. | Current medical research and opinion 20090201 |
| Formoterol and tiotropium compared with tiotropium alone for treatment of COPD. | COPD 20090201 |
| FDA panel: ban 2 popular asthma drugs. | JAMA 20090128 |
| [Exogenous allergic alveolitis]. | Praxis 20090107 |
| Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials. | The European respiratory journal 20090101 |
| Lung function and asthma control with beclomethasone and formoterol in a single inhaler. | Respiratory medicine 20090101 |
| Safety of long-acting beta-agonists: urgent need to clear the air remains. | The European respiratory journal 20090101 |
| [Long-acting bronchodilators (formoterol and salmeterol) for treatment of asthma]. | Pneumologie (Stuttgart, Germany) 20090101 |
| Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children. | The Cochrane database of systematic reviews 20090101 |
| Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. | Respiratory research 20090101 |
| Arformoterol tartrate in the treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease. | Drugs of today (Barcelona, Spain : 1998) 20090101 |
| Inhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide. | Allergy and asthma proceedings 20090101 |
| Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children. | The Cochrane database of systematic reviews 20090101 |
| [Efficacy of one combined inhaled drug in the treatment of patients with bronchial asthma depending on the disease duration]. | Terapevticheskii arkhiv 20090101 |
| [Beta 2 agonists between the FDA, Cochrane and reality]. | Pneumologia (Bucharest, Romania) 20090101 |
| [Budesonide/formoterol maintenance and reliever therapy: an effective and easy approach to asthma management]. | Tuberkuloz ve toraks 20090101 |
| Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children. | The Cochrane database of systematic reviews 20090101 |
| [Effect of transfer factor on treatment with glucocorticoids in a group of pediatric patients with persistent moderate allergic asthma]. | Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20090101 |
| Systemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combination. | Clinical pharmacokinetics 20090101 |
| Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm. | BMC genomics 20090101 |
| Comparative in vitro performance of valved holding chambers with a budesonide/formoterol pressurized metered-dose inhaler. | Allergy and asthma proceedings 20090101 |
| The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. | Respiratory research 20090101 |
| [Reduction of stuttering through bronchodilatation with beta2 sympathomimetic drug formoterol]. | Casopis lekaru ceskych 20090101 |
| Nuclear HSP90 and HSP70 in COPD patients treated with formoterol or formoterol and corticosteroids. | European journal of medical research 20090101 |
| Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapy. | European journal of medical research 20090101 |
| Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control. | Chest 20081201 |
| Rational timing of combination therapy with tiotropium and formoterol in moderate and severe COPD. | Respiratory medicine 20081201 |
| A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany. | International journal of clinical practice 20081201 |
| Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*. | Current medical research and opinion 20081201 |
| Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma. | Allergy 20081201 |
| Expression of CREB-binding protein and peroxisome proliferator-activated receptor gamma during formoterol or formoterol and corticosteroid therapy of chronic obstructive pulmonary disease. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20081201 |
| Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data. | Respiratory medicine 20081101 |
| Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction. | American journal of physiology. Lung cellular and molecular physiology 20081101 |
| Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study. | Respiratory medicine 20081101 |
| Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD. | Journal of clinical pharmacology 20081101 |
| Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. | Medicine 20081101 |
| Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20081101 |
| The safety of formoterol among patients with asthma using inhaled corticosteroids. Systematic review and meta-analysis. | Polskie Archiwum Medycyny Wewnetrznej 20081101 |
| Regular treatment with formoterol for chronic asthma: serious adverse events. | The Cochrane database of systematic reviews 20081008 |
| Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD. | Respiratory medicine 20081001 |
| Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults. | Biopharmaceutics & drug disposition 20081001 |
| Inflammatory and functional effects of increasing asthma treatment with formoterol or double dose budesonide. | Respiratory medicine 20081001 |
| Nebulized formoterol fumarate: Dose selection and pharmacokinetics. | Pulmonary pharmacology & therapeutics 20081001 |
| A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma. | Respiratory medicine 20081001 |
| Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions. | The Annals of pharmacotherapy 20081001 |
| Electrostacking online sample pre-concentration capillary electrophoresis with amperometric detection for beta2-agonists in human urine. | Journal of separation science 20081001 |
| Exhaled carbon monoxide levels: as a marker of clinical severity and control of asthma. | The Journal of asthma : official journal of the Association for the Care of Asthma 20081001 |
| Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. | COPD 20081001 |
| Single-dose pharmacokinetics and safety pharmacodynamics of formoterol delivered by two different dry powder inhalers. | Journal of aerosol medicine and pulmonary drug delivery 20080901 |
| Structural evaluation of the glucuronides of morphine and formoterol using chemical derivatization with 1,2-dimethylimidazole-4-sulfonyl chloride and liquid chromatography/ion trap mass spectrometry. | Rapid communications in mass spectrometry : RCM 20080901 |
| Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20080901 |
| The risk of asthma mortality with inhaled long acting beta-agonists. | Postgraduate medical journal 20080901 |
| Role of arformoterol in the management of COPD. | International journal of chronic obstructive pulmonary disease 20080901 |
| Effect of COPD treatments on MRP1-mediated transport in bronchial epithelial cells. | International journal of chronic obstructive pulmonary disease 20080901 |
| Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD. | Chest 20080801 |
| A pharmacokinetic/pharmacodynamic study comparing arformoterol tartrate inhalation solution and racemic formoterol dry powder inhaler in subjects with chronic obstructive pulmonary disease. | Pulmonary pharmacology & therapeutics 20080801 |
| The adrenergic receptor subtypes present in frog (Rana esculenta) skin. | Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20080801 |
| Long-acting beta-agonists and exercise. | The Journal of allergy and clinical immunology 20080801 |
| Budesonide-formoterol combination inhaler. | Canadian family physician Medecin de famille canadien 20080801 |
| Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial. | Therapeutic advances in respiratory disease 20080801 |
| Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. | The Cochrane database of systematic reviews 20080716 |
| Intramuscular beta2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury. | Journal of applied physiology (Bethesda, Md. : 1985) 20080701 |
| Relaxations to beta-adrenoceptor subtype selective agonists in wild-type and NOS-3-KO mouse mesenteric arteries. | European journal of pharmacology 20080610 |
| [Adrenal insufficiency during inhaled corticosteroid treatment in a child with asthma]. | Ugeskrift for laeger 20080609 |
| Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells. | The European respiratory journal 20080601 |
| The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. | Endocrinology 20080601 |
| Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study. | British journal of clinical pharmacology 20080601 |
| Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. | The Journal of allergy and clinical immunology 20080601 |
| Use of long-acting beta2 agonists in arginine-16 homozygous patients with asthma. | Thorax 20080601 |
| Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline. | Journal of aerosol medicine and pulmonary drug delivery 20080601 |
| Beta2-agonists potentiate corticosteroid-induced neutrophil survival. | COPD 20080601 |
| [Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease]. | Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20080601 |
| Formoterol in the management of chronic obstructive pulmonary disease. | International journal of chronic obstructive pulmonary disease 20080601 |
| Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma. | The European respiratory journal 20080501 |
| Formoterol fumarate and roxithromycin effects on muscle mass in an animal model of cancer cachexia. | Oncology reports 20080501 |
| Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. | The Journal of asthma : official journal of the Association for the Care of Asthma 20080501 |
| Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts. | Allergy 20080401 |
| Efficacy of formoterol Turbuhaler in the emergency treatment of patients with obstructive airway diseases. | Respiratory medicine 20080401 |
| Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. | Respiratory medicine 20080401 |
| Effect of budesonide and formoterol on IL-6 and IL-8 release from primary bronchial epithelial cells. | The Journal of asthma : official journal of the Association for the Care of Asthma 20080401 |
| Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. | Therapeutic advances in respiratory disease 20080401 |
| Bronchodilation of formoterol administered with budesonide: device and formulation effects. | Contemporary clinical trials 20080301 |
| Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients. | Respiratory medicine 20080301 |
| Interactive effects of steroids and beta-agonists on accumulation of type 2 T cells. | The Journal of allergy and clinical immunology 20080301 |
| The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. | Current medical research and opinion 20080301 |
| Salmeterol vs. formoterol: a comparison of rapid bronchodilator effect in a randomized controlled trial. | Indian pediatrics 20080301 |
| Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. | American journal of respiratory and critical care medicine 20080215 |
| Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations. | International journal of pharmaceutics 20080204 |
| Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. | The Journal of allergy and clinical immunology 20080201 |
| Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease. | Respiratory medicine 20080201 |
| Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives. | Expert opinion on pharmacotherapy 20080201 |
| Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials. | COPD 20080201 |
| Formoterol fumarate inhalation powder vs albuterol nebulizer for the treatment of asthma in the acute care setting. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20080201 |
| Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients. | Respiratory medicine 20080201 |
| Once versus twice daily formoterol via Novolizer for patients with moderate to severe COPD--a double-blind, randomised, controlled trial. | Pulmonary pharmacology & therapeutics 20080101 |
| Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler in adolescents and adults with asthma. | Pulmonary pharmacology & therapeutics 20080101 |
| Efficacy and safety of formoterol delivered through the Novolizer, a novel dry powder inhaler (DPI) compared with a standard DPI in patients with moderate to severe asthma. | Pulmonary pharmacology & therapeutics 20080101 |
| Pharmacological characterization of indacaterol, a novel once daily inhaled 2 adrenoceptor agonist, on small airways in human and rat precision-cut lung slices. | The Journal of pharmacology and experimental therapeutics 20080101 |
| Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines. | Current opinion in pulmonary medicine 20080101 |
| Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? | The British journal of general practice : the journal of the Royal College of General Practitioners 20080101 |
| Efficacy and safety of formoterol in Japanese patients with COPD. | Internal medicine (Tokyo, Japan) 20080101 |
| Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients. | Pulmonary pharmacology & therapeutics 20080101 |
| Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all? | Naunyn-Schmiedeberg's archives of pharmacology 20080101 |
| Inhibitory effect of budesonide alone and in combination with formoterol on IL-5 and RANTES production from mononuclear cells. | International archives of allergy and immunology 20080101 |
| Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation. | The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20080101 |
| One hour effects of salbutamol and formoterol on blood pressure, heart rate and oxygen saturation in asthmatics. | Revista portuguesa de pneumologia 20080101 |
| Improvement of asthma therapy by a novel formoterol multidose dry powder inhaler. | Arzneimittel-Forschung 20080101 |
| A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors. | Journal of pharmacological and toxicological methods 20080101 |
| Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. | Allergy and asthma proceedings 20080101 |
| Short term effect of a single dose of formoterol or tiotropium on the isolated nocturnal hypoxemia in stable COPD patients: a double blind randomized study. | European review for medical and pharmacological sciences 20080101 |
| Budesonide/Formoterol pressurized metered-dose inhaler. | Drugs 20080101 |
| Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial. | Drugs 20080101 |
| Combination therapy in asthma: a review. | Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria 20080101 |
| Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations. | Allergologia et immunopathologia 20080101 |
| Cost-effectiveness of combination therapy for chronic obstructive pulmonary disease. | Canadian respiratory journal 20080101 |
| Symbicort: a pharmacoeconomic review. | Journal of medical economics 20080101 |
| Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. | Lancet (London, England) 20071222 |
| Effects of formoterol on endurance performance in athletes at an ambient temperature of -20 degrees C. | Scandinavian journal of medicine & science in sports 20071201 |
| Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. | Respiratory medicine 20071201 |
| Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease. | Expert opinion on pharmacotherapy 20071201 |
| [COPD--comparison between once- and twice daily administration of formoterol]]. | Pneumologie (Stuttgart, Germany) 20071201 |
| Formoterol (Perforomist) for COPD. | The Medical letter on drugs and therapeutics 20071119 |
| Anti-inflammatory activity of beta2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor. | The European respiratory journal 20071101 |
| Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. | International journal of clinical practice 20071101 |
| The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells. | The Journal of allergy and clinical immunology 20071101 |
| Effects of formoterol on exercise tolerance in severely disabled patients with COPD. | Respiratory medicine 20071001 |
| Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs. | Current medical research and opinion 20071001 |
| Some pharmacodynamic effects of eformoterol in the horse. | Journal of veterinary pharmacology and therapeutics 20071001 |
| Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. | Allergy 20071001 |
| Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy. | Allergy 20071001 |
| Comparison of the effects of two long-acting beta2-agonists on cytokine secretion by human airway epithelial cells. | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20071001 |
| Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial. | Clinical therapeutics 20071001 |
| Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD. | Current medical research and opinion 20071001 |
| Change page: Way forward is not obvious at asthma crossroads. | BMJ (Clinical research ed.) 20070922 |
| [New concept for better compliance. Preventing errors in asthma therapy]. | MMW Fortschritte der Medizin 20070913 |
| Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control. | BMJ (Clinical research ed.) 20070908 |
| Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD. | Respiratory medicine 20070901 |
| Synergistic effect of formoterol and mometasone in a mouse model of allergic lung inflammation. | British journal of pharmacology 20070901 |
| How much is too much? The treatment of mild asthma. | The European respiratory journal 20070901 |
| Inhaled mannitol changes the sputum properties in asthmatics with mucus hypersecretion. | Respirology (Carlton, Vic.) 20070901 |
| Adjustable maintenance dosing or total asthma control? Marketing combination inhalers. | The Israel Medical Association journal : IMAJ 20070901 |
| Tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting beta2-agonists. | Respiratory medicine 20070801 |
| Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide. | Respiratory medicine 20070801 |
| Systematic review and meta-analysis of budesonide/formoterol in a single inhaler. | Current medical research and opinion 20070801 |
| Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. | Current medical research and opinion 20070801 |
| Attenuation of age-related muscle wasting and weakness in rats after formoterol treatment: therapeutic implications for sarcopenia. | The journals of gerontology. Series A, Biological sciences and medical sciences 20070801 |
| Arformoterol (Brovana) for COPD. | The Medical letter on drugs and therapeutics 20070702 |
| Effects of topical formoterol alone and in combination with budesonide in a pollen season model of allergic rhinitis. | Respiratory medicine 20070601 |
| Effect of formoterol and salmeterol on IL-6 and IL-8 release in airway epithelial cells. | Respiratory medicine 20070601 |
| Acute asthma intervention: insights from the STAY study. | The Journal of allergy and clinical immunology 20070601 |
| Comparison and optimal use of fixed combinations in the management of COPD. | International journal of chronic obstructive pulmonary disease 20070601 |
| Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and bronchodilators for severe and very severe COPD patients. | International journal of chronic obstructive pulmonary disease 20070601 |
| The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study. | Respiratory medicine 20070501 |
| Validation of high-performance liquid chromatography assay for quantification of formoterol in urine samples after inhalation using UV detection technique. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501 |
| Effects of formoterol and BRL 37344 on human umbilical arteries in vitro in normotensive and pre-eclamptic pregnancy. | Vascular pharmacology 20070501 |
| Formoterol and beclomethasone dipropionate interact positively in antagonising bronchoconstriction and inflammation in the lung. | Pharmacological research 20070501 |
| Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. | Bone marrow transplantation 20070501 |
| Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. | International journal of clinical practice 20070501 |
| A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma. | Emergency medicine journal : EMJ 20070501 |
| Lipid peroxides in stable asthmatics receiving inhaled steroids and long-acting beta2 -agonists. | Respirology (Carlton, Vic.) 20070501 |
| Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. | Clinical therapeutics 20070501 |
| Influence of carrier on the performance of dry powder inhalers. | International journal of pharmaceutics 20070404 |
| Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. | The European respiratory journal 20070401 |
| Onset of action of formoterol versus salmeterol. | Respiratory medicine 20070401 |
| Multi-detection of corticosteroids in sports doping and veterinary control using high-resolution liquid chromatography/time-of-flight mass spectrometry. | Analytica chimica acta 20070314 |
| Randomised trial comparing as-needed versus regular treatment with formoterol in patients with persistent asthma. | Respiratory medicine 20070301 |
| Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi. | The European respiratory journal 20070301 |
| Post hoc analysis and claims of superiority in the EXCEL trial. | Respiratory medicine 20070301 |
| Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease. | Pharmacotherapy 20070301 |
| Scientific rationale for using a single inhaler for asthma control. | The European respiratory journal 20070301 |
| Asthma--is survival good enough? | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20070301 |
| The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge. | The Journal of allergy and clinical immunology 20070201 |
| Interfaces to connect the HandiHaler and Aerolizer powder inhalers to a tracheostomy tube. | Respiratory care 20070201 |
| Determination of formoterol in rat plasma by liquid chromatography-electrospray ionisation mass spectrometry. | Die Pharmazie 20070201 |
| Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. | Clinical therapeutics 20070201 |
| Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients. | Pulmonary pharmacology & therapeutics 20070101 |
| Cardiac safety of formoterol 12 microg twice daily in patients with chronic obstructive pulmonary disease. | Pulmonary pharmacology & therapeutics 20070101 |
| Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway. | American journal of respiratory cell and molecular biology 20070101 |
| A randomized, double-blind trial of the effect of anti-asthma treatment on lung function in children with asthma. | Pulmonary pharmacology & therapeutics 20070101 |
| In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers. | Pharmaceutical research 20070101 |
| Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue. | Neuromuscular disorders : NMD 20070101 |
| Disease-specific expression and regulation of CCAAT/enhancer-binding proteins in asthma and chronic obstructive pulmonary disease. | The Journal of allergy and clinical immunology 20070101 |
| Cooperative inhibitory effects of budesonide and formoterol on eosinophil superoxide production stimulated by bronchial epithelial cell conditioned medium. | International archives of allergy and immunology 20070101 |
| Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. | Canadian respiratory journal 20070101 |
| ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD? | Drugs 20070101 |
| Formoterol turbuhaler is as effective as salbutamol diskus in relieving adenosine-induced bronchoconstriction in children. | Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20070101 |
| The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics. | Lung 20070101 |
| The effectiveness of asthma therapy alternatives and evaluating the effectivity of asthma therapy by interleukin-13 and interferon gamma levels in children. | Allergy and asthma proceedings 20070101 |
| Effect of formoterol on allergen-induced cytokine synthesis by atopic asthmatics. | International archives of allergy and immunology 20070101 |
| Measurement of glomerular filtration rate in the conscious rat. | Journal of pharmacological and toxicological methods 20070101 |
| Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. | Respiratory research 20070101 |
| Canadian economic evaluation of budesonide-formoterol as maintenance and reliever treatment in patients with moderate to severe asthma. | Canadian respiratory journal 20070101 |
| Economic evaluations. | Canadian respiratory journal 20070101 |
| Lung deposition of formoterol HFA (Atimos/Forair) in healthy volunteers, asthmatic and COPD patients. | Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20070101 |
| Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma. | Drugs 20070101 |
| Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database. | Drug safety 20070101 |
| Does the combination of inhaled steroids with long acting beta2 agonists decrease the risk for osteoporosis? A 1-year prospective follow-up study. | Rheumatology international 20061201 |
| Formoterol as a rescue medication for asthma. | Expert opinion on pharmacotherapy 20061201 |
| The effect of formoterol inhalation on endurance performance in hypobaric conditions. | Medicine and science in sports and exercise 20061201 |
| Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. | Chest 20061201 |
| Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study. | Respiratory medicine 20061101 |
| The controversy over long-acting beta agonists: examining the evidence. | Cleveland Clinic journal of medicine 20061101 |
| Relaxant effects of beta-adrenoceptor agonist formoterol and BRL 37344 on bovine iris sphincter and ciliary muscle. | European journal of pharmacology 20061024 |
| Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study. | The European respiratory journal 20061001 |
| Opposing actions of (R,R)-isomers and (S,S)-isomers of formoterol on T-cell function. | The Journal of allergy and clinical immunology 20061001 |
| IGF-1 is downregulated in experimental cancer cachexia. | American journal of physiology. Regulatory, integrative and comparative physiology 20060901 |
| Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. | Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 20060901 |
| Effect of formoterol fumarate treatment on exercise-induced bronchoconstriction in children. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060901 |
| Beta2-Adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis. | Circulation 20060829 |
| Budesonide plus formoterol for reliever therapy in asthma. | Lancet (London, England) 20060826 |
| Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. | Lancet (London, England) 20060826 |
| Pharmacological management of mild or moderate persistent asthma. | Lancet (London, England) 20060826 |
| Effects of ethylcellulose and 2-octyldodecanol additives on skin permeation and irritation with ethylene-vinyl acetate copolymer matrix patches containing formoterol fumarate. | Biological & pharmaceutical bulletin 20060801 |
| Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPD. | COPD 20060801 |
| Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. | The Cochrane database of systematic reviews 20060719 |
| Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease. | The Cochrane database of systematic reviews 20060719 |
| Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation. | Respiratory medicine 20060701 |
| The use of inhaled formoterol in the treatment of asthma. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060701 |
| Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. | Annals of internal medicine 20060620 |
| Summaries for patients. What are the risks of using inhaled long-acting beta-agonist medications for the relief of asthma? | Annals of internal medicine 20060620 |
| Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness. | The European respiratory journal 20060601 |
| Thermodynamic stability and crystal structures for polymorphs and solvates of formoterol fumarate. | Journal of pharmaceutical sciences 20060501 |
| Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. | Respirology (Carlton, Vic.) 20060501 |
| Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma. | Chest 20060501 |
| Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. | The European respiratory journal 20060501 |
| Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. | Current medical research and opinion 20060501 |
| High performance liquid chromatography assay method for simultaneous quantitation of formoterol and budesonide in Symbicort Turbuhaler. | Journal of pharmaceutical and biomedical analysis 20060411 |
| Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma. | Respiratory medicine 20060401 |
| Safety and tolerability of high-dose formoterol (via Aerolizer) and salbutamol in patients with chronic obstructive pulmonary disease. | Respiratory medicine 20060401 |
| Formoterol Turbuhaler as reliever medication in patients with acute asthma. | The European respiratory journal 20060401 |
| Long-acting beta-agonists role in asthma management. | The Journal of family practice 20060401 |
| Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases. | European journal of pharmacology 20060308 |
| Adjustable maintenance dosing with budesonide/formoterol or budesonide: double-blind study. | Respiratory medicine 20060301 |
| Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. | British journal of pharmacology 20060301 |
| Improved lung function and symptom control with formoterol on demand in asthma. | The European respiratory journal 20060301 |
| Formulation and evaluation of ethylene-vinyl acetate copolymer matrix patches containing formoterol fumarate. | Biological & pharmaceutical bulletin 20060301 |
| Is sustained pharmacologic lung volume reduction now possible in COPD? | Chest 20060301 |
| Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. | Chest 20060301 |
| Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD. | Respiratory medicine 20060201 |
| Effects of long-acting bronchodilators and placebo on histamine-induced asthma symptoms and mild bronchusobstruction. | Respiratory medicine 20060201 |
| Something old, something new, something borrowed. COPD treatment today. | Advance for nurse practitioners 20060201 |
| Treatment strategy for asthma: one for all and all for one? | Chest 20060201 |
| Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. | Chest 20060201 |
| Comparison of effects of formoterol and BRL 37344 on isolated term-pregnant rat myometrial strips in vitro. | European journal of pharmacology 20060120 |
| Ultra-sensitive determination of Formoterol in human serum by high performance liquid chromatography and electrospray tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060102 |
| The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler. | Respiratory medicine 20060101 |
| Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease. | Pulmonary pharmacology & therapeutics 20060101 |
| Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. | Pulmonary pharmacology & therapeutics 20060101 |
| Lung fibroblast proteoglycan production induced by serum is inhibited by budesonide and formoterol. | American journal of respiratory cell and molecular biology 20060101 |
| Formoterol induces tolerance to the bronchodilating effect of Salbutamol following methacholine-provocation test in asthmatic children. | Pulmonary pharmacology & therapeutics 20060101 |
| Beta2-adrenergic agonist protects human endothelial cells from hypoxia/reoxygenation injury in vitro. | Critical care medicine 20060101 |
| The 'black box' warning and allergy drugs. | The Journal of allergy and clinical immunology 20060101 |
| Effects of solvents on skin permeation of formoterol fumarate. | Biological & pharmaceutical bulletin 20060101 |
| Formoterol, 24 microg bid, and serious asthma exacerbations: similar rates compared with formoterol, 12 microg bid, with and without extra doses taken on demand, and placebo. | Chest 20060101 |
| Clinically equivalent bronchodilatation achieved with formoterol delivered via Easyhaler and Aerolizer. | Respiration; international review of thoracic diseases 20060101 |
| Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. | Respiratory research 20060101 |
| Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD. | Respiration; international review of thoracic diseases 20060101 |
| Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. | International archives of allergy and immunology 20060101 |
| Inhaled formoterol versus ipratropium bromide in chronic obstructive pulmonary disease. | The Indian journal of chest diseases & allied sciences 20060101 |
| Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. | Drugs 20060101 |
| Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients? | Tuberkuloz ve toraks 20060101 |
| Single-inhaler combination therapy for asthma: a review of cost effectiveness. | PharmacoEconomics 20060101 |
| Peak inspiratory flow rate after methacholine challenge in asthmatic patients and its impact on the effect of formoterol via different inhalers. | Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20060101 |
| Serious adverse events and death associated with treatment using long-acting beta-agonists. | Clinical reviews in allergy & immunology 20060101 |
| A novel apparatus for the determination of solubility in pressurized metered dose inhalers. | Drug development and industrial pharmacy 20060101 |
| Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. | Drugs 20060101 |
| Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. | Respiratory research 20060101 |
| In vitro comparison of two delivery devices for administering formoterol: Foradil P and formoterol ratiopharm single-dose capsule inhaler. | Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20060101 |
| Efficacy of inhaled formoterol in reversing bronchoconstriction. | Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20060101 |
| Bronchodilator use in asthma: the art of prescribing bronchodilators correctly, taking advantage of their differences and reducing risks. | Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20060101 |
| Safety of long-acting beta-agonists--an urgent need to clear the air. | The New England journal of medicine 20051222 |
| Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. | Respiratory medicine 20051201 |
| Safety of formoterol after cumulative dosing via Easyhaler and Aerolizer. | Respiratory medicine 20051201 |
| Heat decreases formoterol delivery. | Chest 20051201 |
| [The management of bronchial asthma during pregnancy--Hungarian experiences]. | Orvosi hetilap 20051106 |
| Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease. | Expert opinion on pharmacotherapy 20051101 |
| Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? | The European respiratory journal 20051101 |
| Long-acting beta2-agonists in asthma: safety concerns. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20051025 |
| Evaluating the effectiveness of combination therapy to prevent COPD exacerbations: the value of NNT analysis. | International journal of clinical practice 20051001 |
| Formoterol attenuates neutrophilic airway inflammation in asthma. | Chest 20051001 |
| Long-acting inhaled bronchodilators for COPD--lack of logic continues. | The New Zealand medical journal 20050916 |
| Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. | The European respiratory journal 20050901 |
| Formoterol added to low-dose budesonide has no additional antiinflammatory effect in asthmatic patients. | Chest 20050901 |
| Comparison of the short-term effects of salmeterol and formoterol on heart rate variability in adult asthmatic patients. | Chest 20050901 |
| Bronchoprotection with formoterol via dry powder and metered-dose inhalers in patients with asthma. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20050901 |
| Daily inhaled corticosteroid treatment should be prescribed for mild persistent asthma. Pro. | American journal of respiratory and critical care medicine 20050815 |
| Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. | The European respiratory journal 20050801 |
| Traditional and patient-centred outcomes with three classes of asthma medication. | The European respiratory journal 20050701 |
| Warnings for asthma drugs. | Lancet (London, England) 20050701 |
| [Combined inhaled corticosteroid and long-acting beta-2-agonist in one inhaler in the treatment of chronic obstructive pulmonary disease]. | Ugeskrift for laeger 20050606 |
| Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD. | Respiratory medicine 20050601 |
| Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide. | Respiratory medicine 20050601 |
| Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients. | Respiratory medicine 20050501 |
| Rapid onset of tolerance to beta-agonist bronchodilation. | Respiratory medicine 20050501 |
| Surface energy and interparticle forces correlations in model pMDI formulations. | Pharmaceutical research 20050501 |
| Managing chronic diseases: combination of inhaler treatment in India has shown good results. | BMJ (Clinical research ed.) 20050423 |
| Formoterol used as needed in patients with intermittent or mild persistent asthma. | Respiratory medicine 20050401 |
| The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes. | International journal of sports medicine 20050401 |
| The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. | Clinical therapeutics 20050401 |
| Changes in prescribing of inhaled corticosteroids (1999-2002) in Scotland. | Pharmacoepidemiology and drug safety 20050301 |
| Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics. | Allergy 20050301 |
| Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers. | Chest 20050301 |
| Dosage clarification. | AAOHN journal : official journal of the American Association of Occupational Health Nurses 20050301 |
| Efficacy and safety of formoterol delivered via a new multidose dry powder inhaler (Certihaler) in adolescents and adults with persistent asthma. | The Journal of asthma : official journal of the Association for the Care of Asthma 20050301 |
| Positive interaction of the beta2-agonist CHF 4226.01 with budesonide in the control of bronchoconstriction induced by acetaldehyde in the guinea-pigs. | British journal of pharmacology 20050201 |
| A respiratory therapist-directed protocol for managing inpatients with asthma and COPD incorporating a long-acting bronchodilator. | The Journal of asthma : official journal of the Association for the Care of Asthma 20050201 |
| Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. | American journal of respiratory and critical care medicine 20050115 |
| The effect of formoterol over 24 h in patients with asthma: the role of enantiomers. | Pulmonary pharmacology & therapeutics 20050101 |
| Cost-effectiveness of formoterol and salbutamol as asthma reliever medication in Sweden and in Spain. | International journal of clinical practice 20050101 |
| Safety and tolerability of high-dose formoterol (Aerolizer) and salbutamol (pMDI) in patients with mild/moderate, persistent asthma. | Pulmonary pharmacology & therapeutics 20050101 |
| Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma. | Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20050101 |
| Comparison of the bronchodilating effects of formoterol and albuterol delivered by hydrofluoroalkane pressurized metered-dose inhaler. | Treatments in respiratory medicine 20050101 |
| Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone. | PharmacoEconomics 20050101 |
| Modulite: a simple solution to a difficult problem. | Respiration; international review of thoracic diseases 20050101 |
| A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients. | Respiration; international review of thoracic diseases 20050101 |
| A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients. | Respiration; international review of thoracic diseases 20050101 |
| Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients. | Respiration; international review of thoracic diseases 20050101 |
| A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients. | Respiration; international review of thoracic diseases 20050101 |
| Bronchoprotective and bronchodilator effects of an HFA pMDI vs. a CFC pMDI and a DPI containing formoterol in asthma patients. | Respiration; international review of thoracic diseases 20050101 |
| Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma. | PharmacoEconomics 20050101 |
| Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. | Drugs 20050101 |
| Inhaled salmeterol/fluticasone propionate: a review of its use in asthma. | Drugs 20050101 |
| Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial. | Respiratory research 20050101 |
| [New study of asthma therapy]. | Krankenpflege Journal 20050101 |
| Montelukast versus formoterol as second-line therapy in asthmatic children exposed to relevant allergens. | Allergy and asthma proceedings 20050101 |
| [The beta2-adrenergic receptor agonists in the treatment of chronic obstructive pulmonary disease]. | Przeglad lekarski 20050101 |
| Combination therapy with maintenance budesonide and formoterol in COPD. | The European respiratory journal 20041201 |
| Improving quality of life in asthmatic children. | Indian journal of pediatrics 20041201 |
| An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma. | Respiratory medicine 20041101 |
| Combination therapy in asthma--fixed or variable dosing in different patients? | Current medical research and opinion 20041101 |
| Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study. | British journal of clinical pharmacology 20041001 |
| Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline. | British journal of clinical pharmacology 20041001 |
| An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study. | Current medical research and opinion 20041001 |
| Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. | Clinical therapeutics 20041001 |
| Long-chain formoterol analogues: an investigation into the effect of increasing amino-substituent chain length on the beta2-adrenoceptor activity. | Bioorganic & medicinal chemistry letters 20040920 |
| Receptor imaging in the thorax with PET. | European journal of pharmacology 20040919 |
| Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. | Cancer research 20040915 |
| Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction. | Respiratory medicine 20040901 |
| Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. | Current medical research and opinion 20040901 |
| Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20040901 |
| Optimization and validation of a gas chromatographic method for analysis of (RS,SR)-diastereoisomeric impurity in formoterol fumarate. | Journal of chromatography. A 20040806 |
| Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol. | Thorax 20040801 |
| The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing. | Current medical research and opinion 20040801 |
| Modulation of beta2- and beta3-adrenoceptor-mediated relaxation of rat oesophagus smooth muscle by protein kinase C. | European journal of pharmacology 20040708 |
| Efficacy and tolerability of Formoterol Turbuhaler in children. | International journal of clinical practice 20040701 |
| Mitochondrial dysfunction and rod-like lesions associated with administration of beta2 adrenoceptor agonist formoterol. | Neuromuscular disorders : NMD 20040601 |
| [Impact of the long active beta-2 agonists inhaled therapy on the quality of life in asthmatic patients]. | Anales de medicina interna (Madrid, Spain : 1984) 20040601 |
| Tiotropium (Spiriva) for COPD. | The Medical letter on drugs and therapeutics 20040524 |
| Adjustable and fixed dosing with budesonide/ formoterol via a single inhaler in asthma patients: the ASSURE study. | Respiratory medicine 20040501 |
| Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV(1) reversibility. | Current medical research and opinion 20040501 |
| FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer in chronic obstructive pulmonary disease. | International journal of clinical practice 20040501 |
| (S,S)-formoterol increases the production of IL-4 in mast cells and the airways of a murine asthma model. | International archives of allergy and immunology 20040401 |
| Asthma exacerbations and formoterol. | Chest 20040401 |
| Formoterol and asthma exacerbations. | Chest 20040401 |
| Long-acting beta agonists in asthma therapy. | Current allergy and asthma reports 20040301 |
| The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol. | Respirology (Carlton, Vic.) 20040301 |
| Dose-related efficacy and safety of formoterol (Oxis) Turbuhaler compared with salmeterol Diskhaler in children with asthma. | Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 20040201 |
| Eformoterol Turbohaler compared with salmeterol by dry powder inhaler in asthmatic children not controlled on inhaled corticosteroids. | Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 20040201 |
| [Fixed combination of inhalant steroids and long-acting beta(2) agonists]. | Deutsche medizinische Wochenschrift (1946) 20040130 |
| The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD. | Pulmonary pharmacology & therapeutics 20040101 |
| Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol. | British journal of pharmacology 20040101 |
| Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotype. | European journal of clinical pharmacology 20040101 |
| The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. | British journal of clinical pharmacology 20040101 |
| Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells. | British journal of haematology 20040101 |
| The role of long-acting bronchodilators in the management of stable COPD. | Chest 20040101 |
| Arformoterol: (R,R)-eformoterol, (R,R)-formoterol, arformoterol tartrate, eformoterol-sepracor, formoterol-sepracor, R,R-eformoterol, R,R-formoterol. | Drugs in R&D 20040101 |
| Formoterol protects against platelet-activating factor-induced effects in asthma. | The European respiratory journal 20040101 |
| Budesonide/formoterol: in chronic obstructive pulmonary disease. | Drugs 20040101 |
| Formoterol vs. albuterol administered via Turbuhaler system in the emergency treatment of acute asthma in children. | Allergologia et immunopathologia 20040101 |
| Inspiratory flow rates and volumes with the Aerolizer dry powder inhaler in asthmatic children and adults. | Current medical research and opinion 20040101 |
| Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. | Current medical research and opinion 20040101 |
| Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma. | Respiration; international review of thoracic diseases 20040101 |
| In-vitro intra- and inter-inhaler flow rate-dependent dosage emission from a combination of budesonide and eformoterol in a dry powder inhaler. | Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20040101 |
| Deposition of Foradil P in human lungs: comparison of in vitro and in vivo data. | Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20040101 |
| Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD. | Pulmonary pharmacology & therapeutics 20040101 |
| Formoterol dry-powder inhalation--Novartis/SkyePharma: Foradil MDDPI, Foradil MDPI, Foradil SkyeHaler, formoterol fumarate dry-powder inhalation. | Drugs in R&D 20040101 |
| Preliminary experience with formoterol for the treatment of stuttering. | The Annals of pharmacotherapy 20040101 |
| Profiles of measured and perceived bronchodilation. A placebo-controlled cross-over trial comparing formoterol and salmeterol in moderate persistent asthma. | Pulmonary pharmacology & therapeutics 20040101 |
| Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing. | Pulmonary pharmacology & therapeutics 20040101 |
| Budesonide/formoterol: a review of its use in asthma. | Drugs 20040101 |
| Suppression of histamine-induced tachypnoea in the rhesus monkey by sibenadet: no role for dopamine D2 receptors. | Autonomic & autacoid pharmacology 20040101 |
| A novel propellant-free inhalation drug delivery system for cardiovascular drug safety evaluation in conscious dogs. | Journal of pharmacological and toxicological methods 20040101 |
| Effects of inhaled formoterol compared with salbutamol in ventilated preterm infants. | Pulmonary pharmacology & therapeutics 20040101 |
| Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control. | Respiration; international review of thoracic diseases 20040101 |
| Report on the course of study BZ-1003-BR following the changes in airways in stutterers with the help of pulse oscillometry (MasterScreen IOS). | Acta medica (Hradec Kralove) 20040101 |
| Eformoterol n-of-1 trials in chronic obstructive pulmonary disease poorly reversible to salbutamol. | Chronic respiratory disease 20040101 |
| Validation of a RP-HPLC method for the assay of formoterol and its related substances in formoterol fumarate dihydrate drug substance. | Journal of pharmaceutical and biomedical analysis 20031204 |
| Quantitative nuclear magnetic resonance analysis of solid formoterol fumarate and its dihydrate. | Journal of pharmaceutical sciences 20031201 |
| Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. | The European respiratory journal 20031201 |
| Efficacy and tolerability of formoterol Turbuhaler in children. | International journal of clinical practice 20031201 |
| Formoterol as relief medication in asthma: the jury is still out. | The European respiratory journal 20031101 |
| Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. | The European respiratory journal 20031101 |
| Liquid chromatography/electrospray ionization tandem mass spectrometric screening and confirmation methods for beta2-agonists in human or equine urine. | Journal of mass spectrometry : JMS 20031101 |
| Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma. | British journal of clinical pharmacology 20031101 |
| Tolerability of short-term, high-dose formoterol in healthy volunteers and patients with asthma. | Clinical therapeutics 20031101 |
| Microplate based biosensing with a computer screen aided technique. | Biosensors & bioelectronics 20031030 |
| Acute allergic responses induce a prompt luminal entry of airway tissue eosinophils. | American journal of respiratory cell and molecular biology 20031001 |
| Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing. | International journal of clinical practice 20031001 |
| Budesonide/formoterol in a single inhaler (Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months. | International journal of clinical practice 20031001 |
| State of the art in beta2-agonist therapy: a safety review of long-acting agents. | International journal of clinical practice 20031001 |
| Formoterol used as needed improves health-related quality of life in asthmatic patients uncontrolled with inhaled corticosteroids. | Respiratory medicine 20030901 |
| Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma. | Respiratory medicine 20030901 |
| [Adding an anti-leukotriene: results of the IMPACT study]. | Revue de pneumologie clinique 20030901 |
| Budesonide/formoterol for the treatment of asthma. | Expert opinion on pharmacotherapy 20030801 |
| [Comparison of RR-formoterol with rac-formoterol in bronchodilating effect on human bronchus]. | Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20030801 |
| Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotype. | British journal of clinical pharmacology 20030701 |
| Serious asthma exacerbations in asthmatics treated with high-dose formoterol. | Chest 20030701 |
| Dose dependency between the effect (FEV1) and the administered dose. | Respiratory medicine 20030701 |
| Determination of formoterol by capillary electrophoresis and its application to inhaler capsules. | Archiv der Pharmazie 20030701 |
| Formoterol 12 microg BID administered via single-dose dry powder inhaler in adults with asthma suboptimally controlled with salmeterol or on-demand salbutamol: a multicenter, randomized, open-label, parallel-group study. | Clinical therapeutics 20030701 |
| Retrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, Italy. | Pharmacological research 20030601 |
| Formoterol and ipratropium in COPD. | American journal of respiratory and critical care medicine 20030601 |
| Airway-stabilizing effect of long-acting beta2-agonists as add-on therapy to inhaled corticosteroids. | QJM : monthly journal of the Association of Physicians 20030601 |
| Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified? | Current opinion in pharmacology 20030601 |
| One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma. | Respiratory medicine 20030601 |
| [Recent results of clinical studies of synergistic treatment in obstructive respiratory tract diseases]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20030601 |
| An individualized, adjustable maintenance regimen of budesonide/formoterol provides effective asthma symptom control at a lower overall dose than fixed dosing. | Swiss medical weekly 20030531 |
| Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD. | Respiratory medicine 20030501 |
| A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD. | Respiratory medicine 20030501 |
| Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. | Chest 20030501 |
| Tocolytic effects of formoterol are associated with local change in the progesterone/estradiol ratio. | European journal of obstetrics, gynecology, and reproductive biology 20030425 |
| Effect of a long- and short-acting beta2-agonist on exercise-induced arterial hypoxemia. | Medicine and science in sports and exercise 20030401 |
| Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma. | Respiratory medicine 20030401 |
| The EDICT study. | Respiratory medicine 20030401 |
| Bronchodilating effects of cumulative doses of formoterol from a novel multi-dose inhaler (Airmax). | Respiratory medicine 20030401 |
| [Control of asthma by treatment with inhaled corticosteroids and prolonged action beta 2-agonists in free or fixed combination. Results of the ALISE study]. | Presse medicale (Paris, France : 1983) 20030322 |
| Comparison of bronchodilating and antiinflammatory activities of oral formoterol and its (R,R)-enantiomers. | Acta pharmacologica Sinica 20030301 |
| [Miflonide/Foradil via Aerolizer compared with other anti-inflammatory and anti-obstructive therapeutic regimens]. | Pneumologie (Stuttgart, Germany) 20030301 |
| How to design a negative study. | Chest 20030201 |
| Inhibitory effects of formoterol on lipopolysaccharide-induced premature delivery through modulation of proinflammatory cytokine production in mice. | Reproduction (Cambridge, England) 20030201 |
| Creatininuria in asthmatic children treated with a combination of glucocorticoid and beta-agonist. | The Journal of asthma : official journal of the Association for the Care of Asthma 20030201 |
| Formoterol delivered by Turbuhaler: in pediatric asthma. | Paediatric drugs 20030101 |
| Bronchodilating effects of cumulative doses of formoterol from a novel multi-dose inhaler (Airmax). | Respiratory medicine 20030101 |
| Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. | The European respiratory journal 20030101 |
| Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. | The European respiratory journal 20030101 |
| An economic assessment of inhaled formoterol dry powder versus ipratropium bromide pressurized metered dose inhaler in the treatment of chronic obstructive pulmonary disease. | Clinical therapeutics 20030101 |
| Formoterol thrice weekly does not result in the development of tolerance to bronchoprotection. | Canadian respiratory journal 20030101 |
| Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler. | Pulmonary pharmacology & therapeutics 20030101 |
| A comparison of salmeterol and formoterol in attenuating airway responses to short-acting beta2-agonists. | Pulmonary pharmacology & therapeutics 20030101 |
| Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPD. | Pulmonary pharmacology & therapeutics 20030101 |
| Formoterol (Foradil) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma. | Pulmonary pharmacology & therapeutics 20030101 |
| Formoterol delivered via the dry powder Aerolizer inhaler versus albuterol MDI and placebo in mild-to-moderate asthma: a randomized, double-blind, double-dummy trial. | The Journal of asthma : official journal of the Association for the Care of Asthma 20030101 |
| Inhaled long acting beta agonists for stable chronic asthma. | The Cochrane database of systematic reviews 20030101 |
| Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease. | The Cochrane database of systematic reviews 20030101 |
| Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study. | Canadian respiratory journal 20030101 |
| Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma. | American journal of respiratory medicine : drugs, devices, and other interventions 20030101 |
| Combined budesonide/formoterol turbuhaler treatment of asthma. | The Annals of pharmacotherapy 20021201 |
| Marginal benefits of adding formoterol. | Thorax 20021201 |
| Possibilities of formoterol to enhance the peripheral lung deposition of the inhaled liposome corticosteroids. | Respiratory medicine 20021201 |
| The effects of regular inhaled formoterol and budesonide on preformed Th-2 cytokines in mild asthmatics. | Respiratory medicine 20021201 |
| From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma. | International journal of clinical practice 20021201 |
| Symbicort Turbuhaler: a new concept in asthma management. | International journal of clinical practice 20021201 |
| Tocolytic activity of formoterol against premature delivery in mice. | The Journal of pharmacy and pharmacology 20021201 |
| Regulation of calcium homeostasis in activated human neutrophils--potential targets for anti-inflammatory therapeutic strategies. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20021201 |
| A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol. | Clinical therapeutics 20021201 |
| In vitro sensitization of human bronchus by beta2-adrenergic agonists. | American journal of physiology. Lung cellular and molecular physiology 20021101 |
| Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study. | The European respiratory journal 20021101 |
| [Medication of the month. The combination of budesonide 160 micrograms/formoterol 4.5 micrograms (Symbicort TH)]. | Revue medicale de Liege 20021101 |
| Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. | Lancet (London, England) 20021026 |
| Formoterol provides long-lasting protection against exercise-induced bronchospasm. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20021001 |
| Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma. | The European respiratory journal 20021001 |
| Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose. | Thorax 20020901 |
| [Onset of action of formoterol in patients with moderate to severe, partially reversible airflow obstruction assessed by bodyplethysmography]. | Pneumologie (Stuttgart, Germany) 20020901 |
| Formoterol therapy for chronic obstructive pulmonary disease: a review of the literature. | Pharmacotherapy 20020901 |
| Antagonism of long-acting beta2-adrenoceptor agonism. | British journal of clinical pharmacology 20020901 |
| Stereoselective urinary excretion of formoterol and its glucuronide conjugate in human. | British journal of clinical pharmacology 20020901 |
| Effects of formoterol (Oxis Turbuhaler) and ipratropium on exercise capacity in patients with COPD. | Respiratory medicine 20020801 |
| One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20020801 |
| A randomized, double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20020701 |
| Clinical-pharmacokinetic aspects of prolonged effect duration as illustrated by beta2-agonists. | European journal of clinical pharmacology 20020701 |
| Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients. | European journal of clinical pharmacology 20020701 |
| Delivery of formoterol from a novel multi-dose inhaler Airmax. | Respiratory medicine 20020601 |
| Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients. | Respiratory medicine 20020601 |
| [Asthma therapy. Long-term spasmolytic therapy with rapid effect]. | MMW Fortschritte der Medizin 20020523 |
| Comparison of the effects of salmeterol and formoterol in patients with severe asthma. | Chest 20020501 |
| Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline. | The European respiratory journal 20020501 |
| Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. | The European respiratory journal 20020501 |
| Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma. | Respiratory medicine 20020501 |
| Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD. | Chest 20020401 |
| New drugs 2002. Part II. | Nursing 20020401 |
| Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine. | The European respiratory journal 20020401 |
| Cost-effectiveness of eformoterol Turbohaler versus salmeterol Accuhaler in children with symptomatic asthma. | Respiratory medicine 20020401 |
| Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease. | Clinical therapeutics 20020401 |
| New therapeutic drugs in the management of chronic obstructive pulmonary disease. | Current opinion in pulmonary medicine 20020301 |
| Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. | Thorax 20020301 |
| Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists. | Respiratory medicine 20020301 |
| [Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20020301 |
| Formoterol fumarate. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020215 |
| Acute formoterol administration has no ergogenic effect in nonasthmatic athletes. | Medicine and science in sports and exercise 20020201 |
| Symbicort: controlling asthma in adults. | Respiratory medicine 20020201 |
| Symbicort: controlling asthma in children. | Respiratory medicine 20020201 |
| The whole story: treatment outcomes with Symbicort. | Respiratory medicine 20020201 |
| The role of inflammation and anti-inflammatory medication in asthma. | Respiratory medicine 20020201 |
| Potential masking effect on dyspnoea perception by short- and long-acting beta2-agonists in asthma. | The European respiratory journal 20020201 |
| A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma. | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20020201 |
| [The effect of triamcinolone acetonide, montelukast, nedocromil sodium, formoterol on levels levels of sICAM-1, sIL-2R in serum and clinical course of asthma in children]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20020201 |
| The safety and efficacy of formoterol (Oxis) turbuhaler plus budesonide (Pulmicort) turbuhaler in mild to moderate asthma: a comparison with budesonide Turbuhaler alone and current non-corticosteroid therapy in Russia. | International journal of clinical practice 20020101 |
| A post-marketing surveillance study of formoterol (Foradil): its use in general practice in England. | Drug safety 20020101 |
| Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: results of a randomized, double-blind clinical study. | Canadian respiratory journal 20020101 |
| Onset of action following formoterol Turbuhaler and salbutamol pMDI in reversible chronic airway obstruction. | Pulmonary pharmacology & therapeutics 20020101 |
| Biological actions of formoterol isomers. | Pulmonary pharmacology & therapeutics 20020101 |
| Formoterol Turbuhaler 4.5 microg (delivered dose) has a rapid onset and 12-h duration of bronchodilation. | Pulmonary pharmacology & therapeutics 20020101 |
| Budesonide/formoterol (Symbicort) is well tolerated and effective in patients with moderate persistent asthma. | International journal of clinical practice 20020101 |
| Single-dose comparison of formoterol (Oxis) Turbuhaler 6 microg and formoterol Aerolizer 12 microg in moderate to severe asthma: a randomised, crossover study. | Pulmonary pharmacology & therapeutics 20020101 |
| Actions other than smooth muscle relaxation may play a role in the protective effects of formoterol on the allergen-induced late asthmatic reaction. | Pulmonary pharmacology & therapeutics 20020101 |
| In vitro testing of two formoterol dry powder inhalers at different flow rates. | Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20020101 |
| Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients. | Pulmonary pharmacology & therapeutics 20020101 |
| Comparison of the protective effect of formoterol and of salmeterol against exercise-induced bronchospasm when given immediately before a cycloergometric test. | Respiration; international review of thoracic diseases 20020101 |
| Managing a variable disease. | Pulmonary pharmacology & therapeutics 20020101 |
| The long and short of beta2-agonists. | Pulmonary pharmacology & therapeutics 20020101 |
| Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma. | The Cochrane database of systematic reviews 20020101 |
| Formoterol delivered via a dry powder inhaler (Aerolizer): results from long-term clinical trials in children. | Current medical research and opinion 20020101 |
| In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler. | Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20020101 |
| Asthma treatment must be always tailored to the individual patient. | Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 20020101 |
| Formoterol: a review of its use in chronic obstructive pulmonary disease. | American journal of respiratory medicine : drugs, devices, and other interventions 20020101 |
| Long-acting beta2-agonists: comparative pharmacology and clinical outcomes. | American journal of respiratory medicine : drugs, devices, and other interventions 20020101 |
| Safety of formoterol Turbuhaler at cumulative dose of 90 microg in patients with acute bronchial obstruction. | The European respiratory journal 20011201 |
| Bronchodilating properties of the VIP receptor agonist Ro 25-1553 compared to those of formoterol on the guinea-pig isolated trachea. | European journal of pharmacology 20011102 |
| Formoterol Turbuhaler for as-needed therapy in patients with mild acute exacerbations of COPD. | Respiratory medicine 20011101 |
| [How compliance is improved. Combined treatment of asthma]. | MMW Fortschritte der Medizin 20011018 |
| Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. | American journal of respiratory and critical care medicine 20011015 |
| Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil Aerolizer) with salbutamol (Ventodisk). | Respiratory medicine 20011001 |
| Glaucoma associated with metered-dose bronchodilator therapy. | Respiratory medicine 20011001 |
| [Long-acting beta 2-stimulants]. | Nihon rinsho. Japanese journal of clinical medicine 20011001 |
| Long-acting inhaled beta(2)-agonist therapy in asthma. | American journal of respiratory and critical care medicine 20010915 |
| Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. | American journal of respiratory and critical care medicine 20010915 |
| Statistical issues in bioequivalence [correction of bioequivalance]. | Statistics in medicine 20010901 |
| Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma. | American journal of respiratory and critical care medicine 20010901 |
| Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. | American journal of respiratory and critical care medicine 20010901 |
| Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids. | The Journal of the American Osteopathic Association 20010901 |
| A cost-effectiveness study comparing the as-needed use of formoterol (Oxis) and terbutaline (Bricanyl) in patients with moderate to severe asthma. | Respiratory medicine 20010901 |
| Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial. | Clinical therapeutics 20010901 |
| Clinical efficacy with formoterol in the absence of a response to salmeterol: a review. | International journal of clinical practice 20010901 |
| [The effect of triamcinolone, montelukast and formoterol on serum levels of il-4, IgE and clinical parameters in children with asthma]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20010901 |
| Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. | The European respiratory journal 20010801 |
| Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists. | The European respiratory journal 20010801 |
| Beta2-agonists--from pharmacological properties to everyday clinical practice. | Respiratory medicine 20010801 |
| Clinical outcome of adding long-acting beta-agonists to inhaled corticosteroids. | Respiratory medicine 20010801 |
| Formoterol used as needed--clinical effectiveness. | Respiratory medicine 20010801 |
| Formoterol in clinical practice--safety issues. | Respiratory medicine 20010801 |
| Formoterol--where does it fit in the current guidelines? | Respiratory medicine 20010801 |
| Pharmacological similarities and differences between beta2-agonists. | Respiratory medicine 20010801 |
| Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer. | American journal of respiratory and critical care medicine 20010715 |
| Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. | Thorax 20010701 |
| Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD. | Chest 20010701 |
| Lost in the labyrinth of end points. | Chest 20010701 |
| Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes. | Respiratory medicine 20010701 |
| On-demand relief treatment for asthma. | Lancet (London, England) 20010609 |
| On-demand relief treatment for asthma. | Lancet (London, England) 20010609 |
| Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis. | Respiratory medicine 20010601 |
| Adding formoterol to budesonide in moderate asthma--health economic results from the FACET study. | Respiratory medicine 20010601 |
| Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. | The European respiratory journal 20010601 |
| Formoterol (Foradil Aerolizer) for asthma. | The Medical letter on drugs and therapeutics 20010514 |
| [Precise direction or flexible self-control. How strictly must the asthma patient adhere to medical advice?]. | MMW Fortschritte der Medizin 20010510 |
| A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients. | Chest 20010501 |
| In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study. | Chest 20010501 |
| [Bronchial asthma. Combination therapy becomes simpler]. | MMW Fortschritte der Medizin 20010405 |
| Long-acting asthma medication, new inhaler approved by FDA. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010401 |
| Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling. | International journal of clinical practice 20010401 |
| Single-isomer beta-agonists. | Pharmacotherapy 20010301 |
| [Solid combination of budesonide and formoterol in the treatment of bronchial asthma]. | Pneumologie (Stuttgart, Germany) 20010301 |
| Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol. | The European respiratory journal 20010301 |
| Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma. | The European respiratory journal 20010301 |
| [Experimental research on permeability injury of pulmonary microvascular endothelial cells monolayer induced by tumor necrosis factor]. | Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20010201 |
| Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial. | Lancet (London, England) 20010127 |
| Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. | Pulmonary pharmacology & therapeutics 20010101 |
| Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD. | Pulmonary pharmacology & therapeutics 20010101 |
| A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20010101 |
| Comparison between formoterol 12 microg b.i.d. and on-demand salbutamol in moderate persistent asthma. | Respiratory medicine 20010101 |
| Inhaled budesonide/formoterol combination. | Drugs 20010101 |
| Development of a lyophilized formulation for (R,R)-formoterol (L)-tartrate. | Drug development and industrial pharmacy 20010101 |
| Comparison of the anti-bronchoconstrictor activities of inhaled formoterol, its (R,R)- and (S,S)-enantiomers and salmeterol in the rhesus monkey. | Pulmonary pharmacology & therapeutics 20010101 |
| Is there a need for another inhalative beta(2)-agonist besides formoterol in patients with asthma? | Respiration; international review of thoracic diseases 20010101 |
| In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler. | Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20010101 |
| Tachyphylaxis following regular use of formoterol in exercise-induced bronchospasm. | Journal of investigational allergology & clinical immunology 20010101 |
| Adrenaline hypothesis: effect of formoterol on noradrenaline release. | Journal of autonomic pharmacology 20010101 |
| beta(2)-adrenoceptor agonist suppresses renal tumour necrosis factor and enhances interleukin-6 gene expression induced by endotoxin. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20001201 |
| Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype. | The American journal of medicine 20000801 |
| Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists. | Molecular pharmacology 19991101 |
| Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action. | Respiration; international review of thoracic diseases 19990101 |
| A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 19980901 |
| Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma. | Drugs 19980201 |
| Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses. | The American review of respiratory disease 19921101 |
| Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease. | Drugs 19910701 |